Editas Medicine, Inc. (NASDAQ:EDIT) appears in 187 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 9,263,312 | -83,802 | -0.90% | $22,880,381.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,204,369 | 4,204,369 | 0.00% | $10,384,791.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 3,972,160 | 932,382 | 30.67% | $9,811,235.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 3,148,570 | 3,148,570 | 0.00% | $7,776,968.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,311,789 | 27,049 | 1.18% | $5,711,437.00 |
| State Street Corp | 31 Mar, 2026 | 2,076,122 | 101,191 | 5.12% | $5,128,021.00 |
| Nuveen, LLC | 31 Mar, 2026 | 1,977,509 | 609 | 0.03% | $4,884,447.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 1,947,384 | 1,164,280 | 148.68% | $4,342,666.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 1,943,893 | 834,303 | 75.19% | $4,801,415.00 |
| Opaleye Management Inc. | 31 Mar, 2026 | 1,926,997 | 1,926,997 | 0.00% | $4,759,683.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 1,549,063 | -83,521 | -5.12% | $3,826,186.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 1,457,715 | 657,868 | 82.25% | $3,596.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,370,497 | 726,300 | 112.75% | $3,385,127.00 |
| Raymond James Financial Inc | 31 Mar, 2026 | 1,293,848 | 109,178 | 9.22% | $3,195,805.00 |
| KENNEDY CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,052,457 | 490,317 | 87.22% | $2,599,569.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 861,326 | 66,655 | 8.39% | $2,127,475.00 |
| Northern Trust Corp | 31 Mar, 2026 | 742,443 | 79,984 | 12.07% | $1,833,834.00 |
| MACKENZIE FINANCIAL CORP | 31 Mar, 2026 | 730,054 | 730,054 | 0.00% | $1,803,233.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 662,389 | -158,604 | -19.32% | $1,636,101.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 614,036 | 614,036 | 0.00% | $1,516,669.00 |